Clinical trial · Interventional
Staying Healthy With Follow-up Care: A Mobile Chatbot Feasibility Study for AYA Cancer Survivors
Staying Healthy With Follow-up Care: A Feasibility Study Utilizing a Chatbot (Penny) Via Mobile Phones to Increase Compliance With Risk Based Survivorship Care (RBSC) Among Adult Survivors of Pediatric and Young Adult Cancers
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The purpose of this project is to identify effective strategies to assist survivors of childhood and young adult cancers (diagnosed between birth and age 39) who have not returned for follow-up cancer care for 3 or more years, to reengage with the health care system. The investigator will evaluate the effect of a novel, bidirectional conversational agent ("Penny"), compared to usual care, to assist patients with scheduling appointments, lab work as well as scans and specialty appointments as needed.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Survivorship | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Penny | Behavioral | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- NO_INTERVENTION
- label
- Usual Care
- type
- EXPERIMENTAL
- label
- Penny text-messaging program
- interventionNames
- Behavioral: Penny
Primary outcomes (4)
- measure
- To evaluate the utilization of a chatbot (Penny) to increase receipt of evidence-based survivorship care in YA survivors of pediatric and YA cancers
- timeFrame
- 1 year
- description
- We will identify adult survivors of pediatric and YA cancers who have not been seen for follow-up care \>3 years and evaluate patients' engagement with Penny to schedule return appointments and adhere to recommended life-long ongoing follow-up care according to the NCCN guidelines. Patients will be monitored over a 16-week period to see if they scheduled a follow-up care appointment.
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Adult patient (age \> 18 years), male or female, diagnosed with cancer as a child or as a young adult, between birth and 39 years of age * Patient possession of a mobile device that can receive SMS texts * Ability to respond to questions and engage with "Penny" in English * Ability to provide informed consent to participate in the study * Approval of the patient's oncology care team for the patient to be involved in the study Exclusion Criteria: * Anyone who does not meet the inclusion criteria * Patients with a history of thyroid cancer or skin cancers
References
Publications (0)
Data not yet available